Apple Bio Medics Profile
Key Indicators
- Authorised Capital ₹ 6.00 M
- Paid Up Capital ₹ 5.34 M
- Company Age 17 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 5.00 M
- Revenue Growth 27.67%
- Profit Growth 55.27%
- Ebitda 64.00%
- Net Worth -8.74%
- Total Assets -26.15%
About Apple Bio Medics
Apple Bio Medics Limited (ABML) is a Public Limited Indian Non-Government Company incorporated in India on 13 June 2007 and has a history of 17 years and seven months. Its registered office is in Kanchipuram, Tamil Nadu, India.
The Company is engaged in the E-Commerce Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 6.00 M and a paid-up capital of Rs 5.34 M.
The company has closed loans amounting to ₹5.00 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Christopher Samuel, Authilingam Raj, Thanumalayaperumal Thiraviam, and Seven other members serve as directors at the Company.
Company Details
- Location
Kanchipuram, Tamil Nadu, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U33110TN2007PLC063907
- Company No.
063907
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
13 Jun 2007
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Apple Bio Medics?
Board Members (10)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Christopher Samuel | Director | 13-Jun-2007 | Current |
Authilingam Raj | Director | 13-Jun-2007 | Current |
Thanumalayaperumal Thiraviam | Director | 13-Jun-2007 | Current |
Chelliah Jeyapal | Director | 13-Jun-2007 | Current |
Anburajan Nayagam | Director | 13-Jun-2007 | Current |
Rasamani Ruskin | Director | 13-Jun-2007 | Current |
Financial Performance of Apple Bio Medics.
Apple Bio Medics Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 27.67% increase. The company also saw a substantial improvement in profitability, with a 55.27% increase in profit. The company's net worth dipped by a decrease of 8.74%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Apple Bio Medics?
In 2020, Apple Bio Medics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0
₹5.00 M
Charges Breakdown by Lending Institutions
- Tamilnad Mercantile Bank Limited : 0.50 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
30 Jan 2015 | Tamilnad Mercantile Bank Limited | ₹1.50 M | Satisfied |
06 Jun 2013 | Tamilnad Mercantile Bank Limited | ₹3.50 M | Satisfied |
How Many Employees Work at Apple Bio Medics?
Unlock and access historical data on people associated with Apple Bio Medics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Apple Bio Medics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Apple Bio Medics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.